Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Tuberculosis (Edinb). 2014 Apr 1;94(3):271–276. doi: 10.1016/j.tube.2014.03.007

Table 1.

Enhancement of drug activity (MIC) with combination treatment.

Drug Alone In Combination ΣFICb
c SB-P8B2 1 × MIC 0.1 X MIC 0.63
Rifampicin 1 × MIC 0.5 × MIC
a

MIC was determined by MABA

b

ΣFIC is the sum of the FICs(MIC of a drug in combination/MIC of that drug alone) for all the drugs tested in the combination. Drugs are considered synergistic when the ΣFIC is less than 0.5 and antagonistic when the ΣFIC is greater than 4.

c

SB-P8B2, was used in combination with rifampicin as a representative of this novel class of FtsZ cell division inhibitors.